← FDA Drug Approvals (Drugs@FDA)
DOXEPIN HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: IXORA LIFESCIENCE · Approved 2021-03-09
Drug application
- FDA Application #
ANDA211619- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- DOXEPIN HYDROCHLORIDE
- Generic name
- DOXEPIN HYDROCHLORIDE
- Active ingredients
- DOXEPIN HYDROCHLORIDE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- IXORA LIFESCIENCE
- Manufacturer
- Leading Pharma, LLC
- First approval
- 2021-03-09
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown